Clinical Trial Update: Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

View source ↗

Summary

Clinical trial investigating repurposed drugs for Leigh syndrome using induced pluripotent stem cell derived neural cells; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leigh Syndrome

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Leigh Syndrome (Maternally Inherited, MILS), Leigh Syndrome (AR, AD, XR) | Status: RECRUITING